# Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase

Study · id `cardio:ct-nct02490306` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02490306](<https://clinicaltrials.gov/study/NCT02490306>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02490306

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT02490306. Non-randomized; no masking; primary purpose diagnostic. Start 2015-07 (registry gives no type); primary completion 2023-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT02490306, source copy `cardio:ctgov-nct02490306-2022-10-28`, retrieved 2026-10-26)
- Start date: 2015-07 (registry gives no type) (ClinicalTrials.gov record NCT02490306, source copy `cardio:ctgov-nct02490306-2022-10-28`, retrieved 2026-10-26)
- Primary completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT02490306, source copy `cardio:ctgov-nct02490306-2022-10-28`, retrieved 2026-10-26)
- Completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT02490306, source copy `cardio:ctgov-nct02490306-2022-10-28`, retrieved 2026-10-26)
- Countries: Sweden (ClinicalTrials.gov record NCT02490306, source copy `cardio:ctgov-nct02490306-2022-10-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02490306-2022-10-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase
- Condition: Stroke
- Intervention (Device): Strokefinder MD100 measurement
- Lead sponsor: Mikael Elam
- Lead sponsor class: OTHER
- Collaborator: Medfield Diagnostics
- Collaborator class: INDUSTRY
- Collaborator: Chalmers University of Technology
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: edd541feb40165fd9c12144b688335a7f2f69f1bc6a0fafa62bf751e01375ab4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
